Trade ALMS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Alumis Inc. (ALMS) is trading at US$7.16, up 2.73% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$3.13B. Over the past 52 weeks, ALMS has traded between US$4.37 and US$31.35. On Syfe you can trade ALMS with $0 commission and add it to your watchlist.
| Previous close | US$6.97 |
|---|---|
| Market cap | US$3.13B |
| 52-week range | US$4.37 – US$31.35 |
| Volume | 1.37M |
| Exchange | US |
Alumis Inc.
Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.
Year: 2024
Top Premarket Gainers
Sep 10, 11:10 AM · MT Newswires
Alumis Insider Bought Shares Worth $10,726,255, According to a Recent SEC Filing
Sep 10, 8:02 AM · MT Newswires
Guggenheim Downgrades Alumis to Neutral From Buy
Sep 3, 11:15 AM · MT Newswires
Sector Update: Healthcare Stocks Advance Late Afternoon
Sep 2, 7:43 PM · MT Newswires
Alumis Inc. (ALMS) stock is trading at US$7.16, +2.73% from the previous close of US$6.97.
The market cap for Alumis Inc. (ALMS) stock is approximately US$3.13B.
The 52-week high for Alumis Inc. (ALMS) stock is US$31.35.
The 52-week low for Alumis Inc. (ALMS) stock is US$4.37.
Alumis Inc. (ALMS) does not currently pay a dividend.
Stay on top of ALMS
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
